A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Mental health professionals reveal the hidden signs of anxiety disorders affecting millions of Americans, from mysterious ...

Political anxiety has become a dominant theme in our culture. We present some of the prominent features and suggestions about ...

“Hyperthyroidism is often linked to Graves’ disease, another autoimmune condition that overstimulates the thyroid. Thyroid ...

Are you worried, restless, or having trouble concentrating most of the time? It could be anxiety. This common mental health ...

AI-driven tools harness ML algorithms to provide insights into anxiety disorders. Supervised ML models, such as logistic ...

Virtual reality meditation effectively reduces depression and anxiety symptoms while improving emotional regulation in ...

Shares in Mind Medicine (MNMD) are surging, following a shift in market sentiment regarding possible growth and the potential ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the company.